JP2021504348A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504348A5 JP2021504348A5 JP2020528244A JP2020528244A JP2021504348A5 JP 2021504348 A5 JP2021504348 A5 JP 2021504348A5 JP 2020528244 A JP2020528244 A JP 2020528244A JP 2020528244 A JP2020528244 A JP 2020528244A JP 2021504348 A5 JP2021504348 A5 JP 2021504348A5
- Authority
- JP
- Japan
- Prior art keywords
- defensin
- human
- pharmaceutical composition
- defensins
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17203527 | 2017-11-24 | ||
| EP17203527.1 | 2017-11-24 | ||
| EP18191954 | 2018-08-31 | ||
| EP18191954.9 | 2018-08-31 | ||
| PCT/EP2018/082022 WO2019101773A2 (en) | 2017-11-24 | 2018-11-21 | Prevention and treatment of graft-versus-host-disease with defensins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504348A JP2021504348A (ja) | 2021-02-15 |
| JP2021504348A5 true JP2021504348A5 (cg-RX-API-DMAC7.html) | 2022-01-04 |
| JP7423523B2 JP7423523B2 (ja) | 2024-01-29 |
Family
ID=64308771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020528244A Active JP7423523B2 (ja) | 2017-11-24 | 2018-11-21 | ディフェンシンによる移植片対宿主病の予防と治療 |
Country Status (15)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102244161B1 (ko) * | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
| KR20230112561A (ko) * | 2022-01-20 | 2023-07-27 | 가톨릭대학교 산학협력단 | 간이식환자 장내균총 분석과 이를 통한 이식상태 모니터링과 면역조절 테라그노시스 조성물 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| DE4343591A1 (de) | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US20060115480A1 (en) * | 2002-12-19 | 2006-06-01 | Yitzchak Hillman | Disease treatment via antimicrobial peptide inhibitors |
| LT2237799T (lt) | 2008-02-01 | 2019-07-25 | Ascendis Pharma A/S | Provaistas, apimantis besiskaidantį linkerį |
| CA2718381A1 (en) * | 2008-03-13 | 2009-09-17 | Immuron Limited | Colostrum-derived immunoglobulin preparation comprising anti-insulin antibodies for the treatment of metabolic syndrome |
| CN102159233A (zh) | 2008-07-18 | 2011-08-17 | 诺维信阿德宁生物技术公司 | 使用哺乳动物β防御素的炎性肠病的治疗 |
| SG172789A1 (en) | 2009-02-11 | 2011-08-29 | Novozymes Biopharma Dk As | Albumin variants and conjugates |
| JP6219277B2 (ja) | 2011-07-08 | 2017-10-25 | ディフェンシン セラピューティクス アンパルトセルスカブDefensin Therapeutics Aps | 炎症性腸疾患の経口治療 |
| ES3010296T3 (en) * | 2014-11-25 | 2025-04-02 | Memorial Sloan Kettering Cancer Center | Intestinal microbiota and gvhd |
| CN104971343B (zh) * | 2015-07-13 | 2018-02-02 | 韩源平 | 防御素在制备治疗代谢综合征药物方面的应用 |
| ES2871117T3 (es) * | 2016-01-26 | 2021-10-28 | Defensin Therapeutics Aps | Procedimientos para modular la microbiota intestinal |
| KR20200095472A (ko) * | 2017-11-10 | 2020-08-10 | 디펜신 테라퓨틱스 에이피에스 | 조산아에서의 점막 방어 및 장/폐 기능의 성숙화 |
-
2018
- 2018-11-21 KR KR1020207015412A patent/KR20200097251A/ko not_active Ceased
- 2018-11-21 WO PCT/EP2018/082022 patent/WO2019101773A2/en not_active Ceased
- 2018-11-21 ES ES18803442T patent/ES3038390T3/es active Active
- 2018-11-21 JP JP2020528244A patent/JP7423523B2/ja active Active
- 2018-11-21 US US16/765,746 patent/US20200291082A1/en not_active Abandoned
- 2018-11-21 BR BR112020010180-0A patent/BR112020010180A2/pt not_active IP Right Cessation
- 2018-11-21 CA CA3083315A patent/CA3083315A1/en active Pending
- 2018-11-21 MX MX2020005370A patent/MX2020005370A/es unknown
- 2018-11-21 PL PL18803442.5T patent/PL3713590T3/pl unknown
- 2018-11-21 AU AU2018371948A patent/AU2018371948A1/en not_active Abandoned
- 2018-11-21 CN CN201880076137.1A patent/CN111741762A/zh active Pending
- 2018-11-21 SG SG11202004207VA patent/SG11202004207VA/en unknown
- 2018-11-21 RU RU2020116903A patent/RU2020116903A/ru unknown
- 2018-11-21 EP EP18803442.5A patent/EP3713590B1/en active Active
-
2020
- 2020-05-12 ZA ZA2020/02669A patent/ZA202002669B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dutta et al. | Mammalian antimicrobial peptides: promising therapeutic targets against infection and chronic inflammation | |
| US9217021B2 (en) | Oral treatment of inflammatory bowel disease | |
| US8536303B2 (en) | Polypeptide inhibitors of HSP27 kinase and uses therefor | |
| CN103476933B (zh) | 白介素1受体的拮抗剂 | |
| Gionchetti et al. | Probiotics—role in inflammatory bowel disease | |
| EP3407905A1 (en) | Methods for modulating intestinal microbiota | |
| CN1520309A (zh) | 治疗口腔及食道损伤的方法和组合物 | |
| BRPI0924481A2 (pt) | Uso de uma beta defensina de mamífero, e, método para tratar uma doença intestinal inflamatória | |
| KR102465341B1 (ko) | 간, 담관 및 췌장 장애의 치료 | |
| RU2020116903A (ru) | Профилактика и лечение реакции "трансплантат против хозяина" с помощью дефензинов | |
| Won et al. | Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide | |
| US20240158798A1 (en) | Non-viral gene/carrier complex for prevention or treatment of acute inflammatory disease | |
| CN116437938A (zh) | 肽制剂及其使用方法 | |
| EP2379587A1 (en) | Melanocortin analogs with antimicrobial activity | |
| ZeNNAmI et al. | A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system | |
| WO2001052901A1 (en) | Drugs for gene therapy | |
| EP4295843A1 (en) | Compositions comprising amino acids for use in the prevention and/or treatment of intestinal diseases | |
| WO2025129029A2 (en) | Combinations of foralumab with glucagon-like peptide 1 (glp-1) agonists or sodium-glucose cotransporter-2 (sglt2) inhibitors and methods of use thereof | |
| Cheng et al. | Delivery of contraceptives to men: lesson from other therapeutic drugs | |
| HK40001163B (en) | Methods for modulating intestinal microbiota | |
| HUP0303798A2 (hu) | Az UK114 fehérjének vagy fragmenseinek alkalmazása az endotoxin-sokk kezelésére és megelőzésére | |
| HK1067049A (en) | Methods and compositions for treating oral and esophageal lesions |